SIGA Technologies, Inc.
General ticker "SIGA" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $475.6M (TTM average)
SIGA Technologies, Inc. does not follow the US Stock Market performance with the rate: -26.9%.
Estimated limits based on current volatility of 1.9%: low 3.47$, high 3.61$
Factors to consider:
- Company pays dividends (annually): last record date 2026-04-07, amount 0.60$ (Y17.44%)
- Total employees count: 46 (+2.2%) as of 2024
- US accounted for 83.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Government contract risks, Limited non government sales, Geopolitical risks, Regulatory and compliance, Third-party risks
- Current price 23.9% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.52$, 7.92$]
- 2026-12-31 to 2027-12-31 estimated range: [4.83$, 8.33$]
Financial Metrics affecting the SIGA estimates:
- Positive: with PPE of 20.2 at the end of fiscal year the price was low
- Positive: 6.62 < Operating cash flow per share per price, % of 9.71
- Positive: Industry inventory ratio change (median), % of 0.12 <= 0.28
- Positive: Operating profit margin, % of 25.06 > 18.40
- Negative: Shareholder equity ratio, % of 90.59 > 64.23
- Positive: Return on assets ratio (scaled to [-100,100]) of 9.59 > 6.02
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: negative Industry operating income (median)
Short-term SIGA quotes
Long-term SIGA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $139.92MM | $138.72MM | $94.57MM |
| Operating Expenses | $56.30MM | $68.74MM | $70.87MM |
| Operating Income | $83.62MM | $69.98MM | $23.70MM |
| Non-Operating Income | $4.16MM | $6.09MM | $6.68MM |
| R&D Expense | $16.43MM | $12.31MM | $19.96MM |
| Income(Loss) | $87.78MM | $76.07MM | $30.38MM |
| Taxes | $19.71MM | $16.86MM | $7.10MM |
| Net Income(Loss)* | $68.07MM | $59.21MM | $23.30MM |
| Stockholders Equity | $196.86MM | $215.80MM | $198.82MM |
| Inventory | $64.22MM | $49.56MM | $49.05MM |
| Assets | $254.35MM | $244.34MM | $219.47MM |
| Operating Cash Flow | $94.80MM | $48.76MM | $43.47MM |
| Capital expenditure | $0.02MM | $0.04MM | $0.36MM |
| Investing Cash Flow | $-0.02MM | $-0.04MM | $-0.36MM |
| Financing Cash Flow | $-43.42MM | $-43.46MM | $-43.55MM |
| Earnings Per Share** | $0.95 | $0.83 | $0.33 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.